跳至主要内容
临床试验/ACTRN12613000820707
ACTRN12613000820707已完成未知

Assessment of radiation dose reduction and image quality of single acquisition, two contrast-injection computed tomography chest/abdomen/pelvis scans compared to the standard two phase imaging protocol for disease staging of oncology patients.

The Alfred0 个研究点目标入组 58 人开始时间: 2013年7月25日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
58

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Diagnosis
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • 1) Referred oncology patients undergoing staging contrast enhanced CT chest/abdomen/pelvis who have had previous CT chest/abdomen/pelvis imaging performed within 1 year.
  • 2) Only adult patients (age >/= 18) will be imaged using the proposed protocol.
  • 3) Only outpatients will be included in the study.
  • 4) Signed informed consent form.

排除标准

  • 1. Oncology patients referred for non-enhanced CT chest/abdomen/pelvis for any reason and including contrast allergy and renal failure.
  • 2. Severe heart failure (this can impair adequate tissue contrast enhancement).
  • 3. Extensive progression of cancer in the period between the two scans. This could prevent direct comparison image quality of the two scans.
  • 4. Pregnancy.
  • 5. Inability to sign own consent (intellectual or mental impairment).

研究者

发起方
The Alfred

相似试验